Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Aclaris Therapeutics, Inc. | acrs-20191231ex321b503ff.htm |
| EX-31.2 - EX-31.2 - Aclaris Therapeutics, Inc. | acrs-20191231ex312c0ce79.htm |
| EX-31.1 - EX-31.1 - Aclaris Therapeutics, Inc. | acrs-20191231ex3119e3c71.htm |
| EX-23.1 - EX-23.1 - Aclaris Therapeutics, Inc. | acrs-20191231ex2310737a9.htm |
| EX-10.20 - EX-10.20 - Aclaris Therapeutics, Inc. | acrs-20191231ex10208578b.htm |
| EX-10.15 - EX-10.15 - Aclaris Therapeutics, Inc. | acrs-20191231ex10157228e.htm |
| EX-10.14 - EX-10.14 - Aclaris Therapeutics, Inc. | acrs-20191231ex101456d79.htm |
| EX-4.2 - EX-4.2 - Aclaris Therapeutics, Inc. | acrs-20191231ex42f1240e5.htm |
| 10-K - 10-K - Aclaris Therapeutics, Inc. | acrs-20191231x10k.htm |
Exhibit 21.1
Subsidiaries of Aclaris Therapeutics, Inc.
|
Name of Subsidiary |
|
Jurisdiction of Incorporation or |
|
|
|
|
|
Aclaris Therapeutics International Limited |
|
United Kingdom |
|
Aclaris Life Sciences, Inc. |
|
Delaware |
|
Confluence Discovery Technologies, Inc. |
|
Delaware |